Undertreatment or overtreatment with statins: where are we?
I García-Fernández-Bravo… - Frontiers in …, 2022 - frontiersin.org
Statins, in addition to healthy lifestyle interventions, are the cornerstone of lipid-lowering
therapy. Other low-density lipoprotein (LDL)-lowering drugs include ezetimibe, bile acid …
therapy. Other low-density lipoprotein (LDL)-lowering drugs include ezetimibe, bile acid …
[PDF][PDF] Success Rate in Achieving Guideline Targets for Lipid Parameters for Atherosclerotic Cardiovascular Risk Prevention in Patients with Type 2 Diabetes mellitus …
H Erman - Southern Clinics of Istanbul Eurasia, 2022 - jag.journalagent.com
Objective: Atherosclerotic cardiovascular disease (ASCVD) is a major cause of morbidity
and mortality worldwide. The aim of the study was to reveal the success rates of glycemic …
and mortality worldwide. The aim of the study was to reveal the success rates of glycemic …
Achieving Target Cholesterol Levels With Type 2 Diabetes is a Challenge.
J Nye - Endocrinology Advisor, 2021 - go.gale.com
A real-world comparison between the lipid profiles of people with type 2 diabetes (T2D) and
guideline recommendations for dyslipidemia suggests current treatment strategies are not …
guideline recommendations for dyslipidemia suggests current treatment strategies are not …